Form 4: Concentra Group Holdings Director Receives Stock Grants

Sentiment:

SEC Form 4 Filing


Cheryl Pegus, a director at Concentra Group Holdings, received two grants of restricted stock on November 26, 2024, totaling 12,992 shares.

Summary

  • Cheryl Pegus, a director of Concentra Group Holdings Parent, Inc., received two grants of restricted stock on November 26, 2024.
  • The first grant was for 6,496 shares, which will vest in equal annual installments over five years.
  • The second grant was also for 6,496 shares, which will vest in full on November 26, 2025, the first anniversary of the grant date, subject to certain exceptions.
  • These transactions were reported in a Form 4 filing with the SEC.
  • The filing also includes a Limited Power of Attorney, dated October 25, 2024, authorizing Timothy F. Ryan to act on behalf of Cheryl Pegus for Section 16 reporting obligations.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice of granting stock to a director, which is generally viewed positively as it aligns interests. There are no negative implications or surprises.

Positives

  • The stock grants align the director's interests with the long-term performance of the company.
  • The vesting schedule encourages continued service and contribution from the director.

Industry Context

Stock grants to directors are a common practice to align their interests with shareholders and incentivize long-term value creation. This is a standard form of compensation in many public and private companies.

Comparison to Industry Standards

  • Stock grants to directors are a common practice across various industries, including healthcare and business services, where Concentra operates.
  • Vesting schedules, such as the five-year and one-year vesting periods in this case, are typical for restricted stock grants to ensure long-term commitment.
  • Companies like UnitedHealth Group and Cigna, which are in the broader healthcare space, also use similar equity-based compensation for their directors.

Stakeholder Impact

  • The stock grants may be viewed positively by shareholders as they align the director's interests with the company's long-term performance.
  • The grants do not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
2024-10-25Date of the Limited Power of Attorney granted by Cheryl Pegus to Timothy F. Ryan.
2024-11-26Date of the restricted stock grants to Cheryl Pegus.
2024-11-29Date of the Form 4 filing.
2025-07-28Expiration date of the notary public's commission.
2025-11-26Date the second stock grant will fully vest.

Keywords

stock grants, restricted stock, Form 4, insider trading, director, Concentra Group Holdings, vesting, equity compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.